Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID 19 hospitalized meta-analysis

HAHPS, 2020
 
NCT04329832
RCThydroxychloroquineazithromycinCOVID 19 hospitalizedsome concern
42/43 inconclusive
  • inconclusive 7 % increase in clinical deterioration (PE) with a moderate degree of certainty due to some concern in risk of bias
PROTECT B, 2020
 
NCT04338698
RCThydroxychloroquineoseltamivirCOVID 19 hospitalizedNA
-/- inconclusive
    Sekhavati, 2020 RCThydroxychloroquinehydroxychloroquineCOVID 19 hospitalizedsome concern
    56/55 inconclusive
    • inconclusive 51 % decrease in deaths (PE) with a moderate degree of certainty due to some concern in risk of bias
    Sekhavati, 2020 RCThydroxychloroquinelopinavir/ritonavirCOVID 19 hospitalizedsome concern
    56/55 inconclusive
    • inconclusive 51 % decrease in deaths (PE) with a moderate degree of certainty due to some concern in risk of bias

    PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
    Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).